Koninklijke Philips N.V. $PHG Stake Raised by Concurrent Investment Advisors LLC

Concurrent Investment Advisors LLC increased its holdings in Koninklijke Philips N.V. (NYSE:PHG) by 100.6% in the 2nd quarter, Holdings Channel reports. The fund owned 25,667 shares of the technology company’s stock after purchasing an additional 12,872 shares during the period. Concurrent Investment Advisors LLC’s holdings in Koninklijke Philips were worth $615,000 as of its most recent SEC filing.

Several other hedge funds have also recently bought and sold shares of the business. Fiduciary Management Inc. WI lifted its stake in Koninklijke Philips by 21.7% in the 1st quarter. Fiduciary Management Inc. WI now owns 7,515,737 shares of the technology company’s stock worth $190,900,000 after acquiring an additional 1,339,055 shares in the last quarter. Dimensional Fund Advisors LP raised its stake in shares of Koninklijke Philips by 2.5% during the 1st quarter. Dimensional Fund Advisors LP now owns 4,396,095 shares of the technology company’s stock worth $111,662,000 after purchasing an additional 106,044 shares in the last quarter. Northern Trust Corp raised its stake in shares of Koninklijke Philips by 5.1% during the 1st quarter. Northern Trust Corp now owns 1,690,402 shares of the technology company’s stock worth $42,936,000 after purchasing an additional 81,653 shares in the last quarter. Perpetual Ltd raised its stake in shares of Koninklijke Philips by 2.6% during the 2nd quarter. Perpetual Ltd now owns 872,646 shares of the technology company’s stock worth $20,926,000 after purchasing an additional 21,898 shares in the last quarter. Finally, Goldman Sachs Group Inc. raised its stake in shares of Koninklijke Philips by 1.5% during the 1st quarter. Goldman Sachs Group Inc. now owns 846,253 shares of the technology company’s stock worth $21,495,000 after purchasing an additional 12,908 shares in the last quarter. 13.67% of the stock is owned by hedge funds and other institutional investors.

Koninklijke Philips Stock Performance

Shares of NYSE PHG opened at $28.54 on Friday. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.81 and a current ratio of 1.26. The firm has a market cap of $27.48 billion, a price-to-earnings ratio of 150.18, a P/E/G ratio of 0.76 and a beta of 0.82. The business’s 50-day simple moving average is $27.69 and its 200-day simple moving average is $25.35. Koninklijke Philips N.V. has a 52 week low of $21.48 and a 52 week high of $32.25.

Koninklijke Philips (NYSE:PHG) last issued its quarterly earnings data on Tuesday, July 29th. The technology company reported $0.41 EPS for the quarter, beating analysts’ consensus estimates of $0.29 by $0.12. The business had revenue of $5.05 billion for the quarter, compared to analyst estimates of $4.35 billion. Koninklijke Philips had a return on equity of 11.95% and a net margin of 1.00%. As a group, equities research analysts expect that Koninklijke Philips N.V. will post 1.63 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of equities research analysts have recently weighed in on the company. Wall Street Zen downgraded Koninklijke Philips from a “buy” rating to a “hold” rating in a research note on Saturday, August 2nd. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Koninklijke Philips in a research note on Wednesday, October 8th. One equities research analyst has rated the stock with a Strong Buy rating, two have given a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, Koninklijke Philips currently has an average rating of “Moderate Buy”.

Koninklijke Philips Profile

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.